Latest News
Capricor Therapeutics, Inc.
- Capricor Therapeutics, Inc. Estimates – XETR:4LN2
- Capricor Therapeutics, Inc. Cash Flow – XETR:4LN2
- Which of Capricor Therapeutics (NASDAQ:CAPR), Evernorth (NASDAQ:XRPN), WISeSat.Space Holdings (NASDAQ:SAIQ) or Julong Holding (NASDAQ:JLHL) Is the Biggest Wildcard Among Wednesday's Pre-Market Decliners?
- Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Open-Label Extension Data and Deramiocel Update for Duchenne Muscular Dystrophy - Slideshow (NASDAQ:CAPR) 2026-10-13
- Investor Nets 94% Gain on Capricor Therapeutics (CAPR) Weekly Ca
- Capricor Highlights Two-Year Deramiocel Data as FDA Decision Nears
- Capricor Therapeutics Tokenized Stock (Ondo)
- Capricor Therapeutics Presents Positive HOPE-3 Open-Label
- Capricor Therapeutics, Inc. stock Analysis: Bearish Trend and Intraday Pause
- Capricor Therapeutics Shares Jump as Two-Year Data Bolster Duchenne Drug Case
- Capricor Therapeutics (CAPR) Shares Surge on Positive Phase 3 Da
- Capricor jumps as study shows longer-term effects of deramiocel (CAPR:NASDAQ)
Headlines from the last 30 days, linking to the original publishers. See all market news →